Actinogen Limited

ASX:ACW ISIN:AU000000ACW3

 
 

News

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 12000

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article
###

1,453 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 3) (Last 30 Days: 18) (Since Published: 1453) 

Company Data

More News Results

  • 2024/03/25: ACW corporate presentation revised licensing slide*
  • 2024/03/20: Notification of buy-back - ACW*
  • 2024/03/20: Actinogen corporate presentation March 2024*
  • 2024/03/07: Application for quotation of securities - ACW*
  • 2024/03/07: ACW XanaCIDD depression trial enters final enrolment phase*
  • 2024/03/06: Actinogen CMO presents at ADPD 2024 conference*
  • 2024/02/26: Actinogen HY2024 financial results two key phase 2 trial*
  • 2024/02/26: Actinogen HY2024 financial report and Appendix 4D*
  • 2024/02/21: Application for quotation of securities - ACW*
  • 2024/02/20: Response to ASX Aware Query*
*refer to company website